From: Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
 | LSD1 IC50 | MLL-rearranged leukemia | Non-MLL leukemia cells | Breast | Prostate | ||
---|---|---|---|---|---|---|---|
MV4-11 | Molm-13 | NB4 | U937 | MCF-7 | LNCaP | ||
1 | 0.0098 | 0.010 | 0.096 | 19.4 | 18.9 | 1.6 | 3.7 |
2 | 0.077 | 0.084 | 0.32 | 18.9 | 34.6 | 6.6 | 10.0 |
3 | 0.035 | 0.020 | 0.18 | >50 | >50 | 13.5 | 29.9 |
4 | 5.3 | 1.4 | 12 | >50 | 17.5 | >50 | >50 |